Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilxi in facial papulopustular rosacea
NCT04608500Phase 3Completed
- Sponsor
- Vyne Therapeutics
- Start
- Jun 2017
- Primary completion
- Jul 2018
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zilxi in papulopustular rosacea, sponsored by Vyne Therapeutics. Started Jun 2017; status: completed.
02
Drugs
zilxi
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT04608500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608500.